Real-World Insight That Moves Diabetes Research Forward
We help industry, academic, and advocacy partners move faster and with confidence by turning real-world data into actionable evidence.
Custom Research
- Design studies that answer the right questions.
- Execute research data collection and analysis.
- Integrate participant-reported outcomes with clinical and device data.
- Synthesize report findings into meaningful insights.
Research Study Recruitment
- Recruit faster — without compromising quality.
- Access the T1D Exchange Online Registry.
- Connect to interested individuals who meet study criteria.
- Conduct a wide variety of research projects, including survey, focus groups and in-person studies.
Quality Improvement Initiatives
- Support evidence-informed change at scale by partnering with T1DX-QI centers.
- Connect with one of the largest learning networks of healthcare providers.
- Utilize real-world insight.
- Deploy standardized evidence-based QI methods.
Latest Publications
T1D Exchange Research Highlights from the American Diabetes Association's 86th Scientific Sessions
From June 5-8, 2026, researchers from T1D Exchange and the T1D Exchange Quality Improvement Collaborative (T1DX-QI) shared new findings at the American Diabetes Association's 86th Scientific Sessions, one of the world's largest scientific meetings focused on diabetes research and care.
Read more
Inside the Eledon Islet Cell Transplant Trial: Katie Beth Hand’s Journey to Insulin Independence
On a Friday night, Katie Beth Hand was at Rock N Roll Sushi with a table full of 12-year-old girls when her phone rang.
Read more
T1D Exchange to Present New Research at the American Diabetes Association’s 86th Scientific Sessions
Findings from the T1D Exchange Quality Improvement Collaborative and Registry will be featured in oral presentations, posters, and symposium discussions throughout the meeting. Studies explore early-stage type 1 diabetes screening, diabetes technology adoption, health equity, care delivery, and real-world clinical practices. Findings reflect collaboration across leading endocrinology centers and researchers working to improve outcomes for people living with diabetes. T1D Exchange, a nonprofit organization dedicated to improving outcomes for people living with type 1 diabetes (T1D), announced that researchers from T1D Exchange and partner institutions will present new findings at the American Diabetes Association’s 86th Scientific Sessions, held June 5-8, 2026, in New Orleans, Louisiana. The presentations include research from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) and online patient Registry, with studies focused on early-stage T1D screening and monitoring, diabetes technology use, health equity, healthcare transition practices, and care delivery across diabetes centers. “Our presentations at the 86th Scientific Sessions reflect the strength of collaborative, real-world research and the impact of shared learning across the diabetes community,” said David Walton, MBA, Chief Executive Officer of T1D Exchange. “By bringing together clinical data, implementation expertise, and lived experience, T1D Exchange and our partners continue to identify practical approaches that can improve care delivery and outcomes for people living with diabetes.” A symposium, Quality Improvement Initiatives at Scale: What Have We Learned? will feature insights from T1D Exchange CEO, David Walton, on Saturday, June 6, 3:15 - 4:15 p.m. CT in R07 (Level 2). Two additional oral presentations will cover the topic of early-stage T1D screening and monitoring at endocrinology centers participating in the T1DX-QI network: 1058-OR, Operationalizing Early-Stage Type 1 Diabetes Screening and Monitoring: A Pediatric Multicenter T1D Exchange Quality Improvement Initiative on Friday, June 5 at 2:15 p.m. CT in 245 (Level 2) 1305-OR: Emerging Type 1 Diabetes Screening and Intervention Programs: Insights from 63 Centers in the T1D Exchange Quality Improvement (T1DX-QI) Collaborative on Monday, June 8 at 2:30 p.m. CT in 217 (Level 2) Poster presentations during the meeting will cover a range of topics, including: Efforts to increase diabetes technology use among people living with T1D Approaches to improving equitable access to diabetes technology Workforce, transition-of-care, and billing trends across diabetes centers Experiences with menopause and perimenopause among people living with T1D Agreement between self-reported and laboratory-measured A1C among people living with T1D Use of glucagon-like peptide-1 (GLP-1) receptor agonists in youth-onset type 2 diabetes (T2D) care The T1DX-QI, a national network of endocrinology centers working together to improve diabetes care, includes more than 65 endocrinology centers across the U.S. that contribute de-identified electronic health record data and participate in shared quality improvement initiatives. Together, participating centers help create one of the most comprehensive real-world datasets focused on diabetes care and outcomes in the U.S. View the complete list of T1D Exchange presentations at the 86th Scientific Sessions. About T1D Exchange T1D Exchange is a nonprofit organization dedicated to improving outcomes for people with diabetes through real-world evidence and teamwork. By operating at the intersection of people, data, and research, T1D Exchange works with healthcare professionals, researchers, industry partners, and people living with diabetes to generate evidence that leads to better care, stronger research, and meaningful progress for the diabetes community.
Read more